43 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp00047 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 3.5% inhibition at 10-6 M |
| dbacp00048 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 22.7% inhibition at 10-5 M |
| dbacp00049 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 18.9% inhibition at 10-4 M |
| dbacp00050 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 26.4% inhibition at 10-3 M |
| dbacp00071 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 3.7% inhibition at 10-6 M |
| dbacp00072 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 16.5% inhibition at 10-5 M |
| dbacp00073 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 8.4% inhibition at 10-4 M |
| dbacp00074 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 14.5% inhibition at 10-3 M |
| dbacp00145 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 2.2% inhibition at 10-6 M |
| dbacp00146 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 4.2% inhibition at 10-5 M |
| dbacp00147 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 6.4% inhibition at 10-4 M |
| dbacp00148 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 6.2% inhibition at 10-3 M |
| dbacp00178 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 8.1% inhibition at 10-6 M |
| dbacp00179 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 6.9% inhibition at 10-5 M |
| dbacp00180 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 8.1% inhibition at 10-4 M |
| dbacp00181 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 8.6% inhibition at 10-3 M |
| dbacp00212 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 3.0% inhibition at 10-6 M |
| dbacp00213 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 8.4% inhibition at 10-5 M |
| dbacp00214 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 18.5% inhibition at 10-4 M |
| dbacp00215 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 10.6% inhibition at 10-3 M |
| dbacp00246 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 17.7% inhibition at 10-6 M |
| dbacp00247 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 10.9% inhibition at 10-5 M |
| dbacp00248 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 12.1% inhibition at 10-4 M |
| dbacp00249 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 8.1% inhibition at 10-3 M |
| dbacp00286 | Enkephalins7 analogue-23 | YGGFMA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 11.08% inhibition at 10-5 M |
| dbacp00287 | Enkephalins7 analogue-23 | YGGFMA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 47.0% inhibition at 10-3 M |
| dbacp03720 | LCP-3 | WLHV | Plant sources | Inducing apoptosis | Not specified | Caco-2 | Not specified | Not found |
| dbacp06656 | LfcinB (21-25)Pal | RWQWRWQWR | LfcinB | Apoptosis inducing | MTT assay | CaCo-2 | Colorectal Cancer | IC50 = 86 μM |
| dbacp06660 | Ahx-[Pal] | Ahx-RWQWRWQWR | Synthetic | Apoptosis inducing | MTT assay | CaCo-2 | Colorectal Cancer | IC50 = 40 μM |
| dbacp06662 | 9[Orn] [Pal] | RWQWRWQWO | Synthetic | Apoptosis inducing | MTT assay | CaCo-2 | Colorectal Cancer | IC50 = 40 μM |
| dbacp06664 | CH3CO-Ahx-[Pal] | CH3-CO-Ahx-RWQWRWQWR | Synthetic | Apoptosis inducing | MTT assay | CaCo-2 | Colorectal Cancer | IC50 = 31 μM |
| dbacp06665 | 1[dR][Pal] | rWQWRWQWR | Synthetic | Apoptosis inducing | MTT assay | CaCo-2 | Colorectal Cancer | IC50 = 105 μM |
| dbacp06666 | 1[Orn] [Pal] | OWQWRWQWR | Synthetic | Apoptosis inducing | MTT assay | CaCo-2 | Colorectal Cancer | IC50 = 91 μM |
| dbacp06667 | 5[Orn] [Pal] | RWQWOWQWR | Synthetic | Apoptosis inducing | MTT assay | CaCo-2 | Colorectal Cancer | IC50 = 64 μM |
| dbacp06668 | 1[dR] 5[Orn] [Pal] | rWQWOWQWR | Synthetic | Apoptosis inducing | MTT assay | CaCo-2 | Colorectal Cancer | IC50 = 109 μM |
| dbacp07021 | BmPLA2 | FKWQFEMLIMKIAKTSGFMFYSSY | phospholipase A2 isoform from B. moojeni venom | Membrane disruption, selective cancer cytotoxicity | MTT assay | CaCo-2 | Colorectal Cancer | IC50 = 0.6 µM |
| dbacp07278 | LCP-2 | WAHT | Laminaria japonica | Mitochondrial apoptosis via p53 activation. | MTT assay | CaCo-2 | Colon Cancer | IC50 = 100 ± 11.6 μM |
| dbacp07282 | LCP-3 | WHLV | Laminaria japonica | Mitochondrial apoptosis via p53 activation. | MTT assay | CaCo-2 | Colon Cancer | IC50 = 68.2 ± 7.11 μM |
| dbacp07424 | GP-1 | FKEHGY | Ginseng Leaf Peptide | Mitochondrial apoptosis via p53 activation | MTT assay | CaCo-2 | Colon Cancer | IC50 = 104 ± 11.3 µM |
| dbacp07427 | GP-2 | EGFHL | Ginseng Leaf Peptide | Mitochondrial apoptosis via p53 activation | MTT assay | CaCo-2 | Colon Cancer | IC50 = 154 ± 15.8 µM |
| dbacp07430 | GP-3 | FSHTYV | Ginseng Leaf Peptide | Mitochondrial apoptosis via p53 activation | MTT assay | CaCo-2 | Colon Cancer | IC50 = 162 ± 17.1 µM |
| dbacp07539 | AEM-28 | LRKLRKRLLRDWLKAFYDKVAEKLKEAF | Synthetic | LPA reduction suppresses tumor growth | MTS assay | CaCo-2 | Colon Cancer | ~70% cell viability at 10 μg/mL |
| dbacp07545 | AEM-28–2 | Aha-LRRLRRRLLRDWLKAFYDKVAEKLKEAF | Synthetic | LPA reduction suppresses tumor growth | MTS assay | CaCo-2 | Colon Cancer | ~60% cell viability at 10 μg/mL |